There is no such thing as an absolutely safe drug. There never was, and I doubt that there will ever be one. Considering this opening statement, I would like to take you through an historical trip on the evolution of drug therapy, what the risks and benefits are, and what the new era of biotechnolog
Local measures for the reduction of drug emergency risks and drug mortality risks
β Scribed by H.-Jochen Zenker; Christel Zenker; Peter Lang
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 262 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0379-0738
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Purpose: This study examines the risk of all-cause and cardiac-related mortality associated with calcium channel blockers (ccbs) and other antihypertensives/diuretics compared with beta-blockers among an elderly cohort. we explored variations in mortality risk according to ccb formulation, dose
## Abstract ## Background Acute perforated colonic diverticular disease has a mortality rate of up to 30 per cent, but little is known about its aetiology. The aim of this study was to test the hypothesis that three classes of drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs), opioid an
Information from a Drug Dispensing Database Table 1 Γ Concomitant use of oral xanthines (OX) and medications from four interacting classes (IC), in ambulatory elderly patients (n 995) Risk of Ca-channel Fluoroquinolones Macrolides H 2 -receptor interaction blockers antagonists % OX-users 30.1 19.0 1